ATE458997T1 - Tiermodell zur analyse von tumormetastasierung - Google Patents

Tiermodell zur analyse von tumormetastasierung

Info

Publication number
ATE458997T1
ATE458997T1 AT04776817T AT04776817T ATE458997T1 AT E458997 T1 ATE458997 T1 AT E458997T1 AT 04776817 T AT04776817 T AT 04776817T AT 04776817 T AT04776817 T AT 04776817T AT E458997 T1 ATE458997 T1 AT E458997T1
Authority
AT
Austria
Prior art keywords
tumor metastasis
animal model
analyzing tumor
study
analyzing
Prior art date
Application number
AT04776817T
Other languages
English (en)
Inventor
Masato Nakamura
Yasuyuki Ohnishi
Original Assignee
Central Inst Exper Animals
Ct For The Advancement Of Heal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Inst Exper Animals, Ct For The Advancement Of Heal filed Critical Central Inst Exper Animals
Application granted granted Critical
Publication of ATE458997T1 publication Critical patent/ATE458997T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G01N33/57525—
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
AT04776817T 2003-07-10 2004-06-18 Tiermodell zur analyse von tumormetastasierung ATE458997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48704403P 2003-07-10 2003-07-10
PCT/US2004/019697 WO2005013682A2 (en) 2003-07-10 2004-06-18 Animal model for the analysis of tumor metastasis

Publications (1)

Publication Number Publication Date
ATE458997T1 true ATE458997T1 (de) 2010-03-15

Family

ID=34135078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04776817T ATE458997T1 (de) 2003-07-10 2004-06-18 Tiermodell zur analyse von tumormetastasierung

Country Status (8)

Country Link
US (1) US20050132427A1 (de)
EP (1) EP1644732B1 (de)
JP (2) JP4663634B2 (de)
AT (1) ATE458997T1 (de)
AU (1) AU2004263079A1 (de)
CA (1) CA2531916A1 (de)
DE (1) DE602004025706D1 (de)
WO (1) WO2005013682A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006039671A2 (en) * 2004-09-29 2006-04-13 Central Institute For Experimental Animals Gene markers of tumor metastasis
CN1920564B (zh) * 2005-08-26 2011-08-24 中国科学院上海生命科学研究院 细胞转录因子ilf-1的应用
JP2007139656A (ja) * 2005-11-21 2007-06-07 Igaku Seibutsugaku Kenkyusho:Kk 食道癌診断キット
US20070283453A1 (en) * 2006-05-31 2007-12-06 Juan Carlos Rodriguez Cimadevilla Animal models of tumor metastasis and toxicity
JP6115801B2 (ja) * 2007-03-27 2017-04-19 イミュノヴィア・アーベー 腺癌の検出のための蛋白質シグネチャー／マーカー
WO2010118782A1 (en) * 2009-04-17 2010-10-21 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer
WO2012106529A1 (en) * 2011-02-02 2012-08-09 The Trustees Of Princeton University Jagged1 as a marker and therapeutic target for breast cancer bone metastasis
WO2012109567A2 (en) 2011-02-11 2012-08-16 The Rockefeller University Treatment of angiogenesis disorders
WO2013035779A1 (ja) * 2011-09-06 2013-03-14 国立大学法人東京大学 細胞間の相互作用の解析方法
EP4335927A3 (de) * 2015-06-16 2024-06-19 The Jackson Laboratory Genetisch veränderte nichtmenschliche tiere und verfahren zur komplementabhängigen zytotoxizität
IL256342B2 (en) 2015-06-23 2023-04-01 Jackson Lab A humanized nsg mouse model with hla-mismatched patient-derived grafts
KR101992817B1 (ko) * 2016-02-15 2019-09-30 고려대학교 산학협력단 폐암 동물모델의 제조방법
WO2017142292A1 (ko) * 2016-02-15 2017-08-24 고려대학교 산학협력단 폐암 동물모델의 제조방법
RU2725273C1 (ru) * 2019-11-05 2020-06-30 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации Способ трансплантации фрагмента нейроэндокринной опухоли поджелудочной железы человека в поджелудочную железу иммунодефицитных мышей
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
PT118269A (pt) 2022-10-20 2024-04-22 Univ Aveiro Pkmyt1 for use in regenerative medicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1338198B1 (de) * 2000-12-01 2007-11-28 Central Institute For Experimental Animals Verfahren zur herstellung einer maus, die für die aufnahme, differenzierung und proliferation von heterogenen zellen geeignet ist, die hierdurch hergestellte maus und ihre verwendung
US7135609B2 (en) * 2001-05-10 2006-11-14 Chugai Seiyaku Kabushiki Kaisha Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors

Also Published As

Publication number Publication date
EP1644732A2 (de) 2006-04-12
WO2005013682A2 (en) 2005-02-17
US20050132427A1 (en) 2005-06-16
EP1644732B1 (de) 2010-02-24
AU2004263079A1 (en) 2005-02-17
WO2005013682A3 (en) 2005-07-28
CA2531916A1 (en) 2005-02-17
JP2011030570A (ja) 2011-02-17
JP4663634B2 (ja) 2011-04-06
DE602004025706D1 (de) 2010-04-08
JP2007527216A (ja) 2007-09-27

Similar Documents

Publication Publication Date Title
ATE458997T1 (de) Tiermodell zur analyse von tumormetastasierung
BR0210918A (pt) Método e aparelho para personalizar ração para animal de estimação
ATE365912T1 (de) Mr-verfahren zur analyse von samen
DE602004025531D1 (de) Ng, programm zur schlüsselworterkennung, mit adaption von schlüsselwort- und nichtschlüsselwortmodellen.
EP1615993A4 (de) Verfahren zur selektion, aufzeichnung und analyse genetischer marker unter verwendung von anwendungen zur erstellung genetischer profile auf breiter grundlage
EP1514436A4 (de) Zweischwellen-aufwärtsstreckenratensteuerung zur ermöglichung von aufwärtsstrecken-einteilung
DE602004012900D1 (de) Verfahren zur Analyse von Leistungsinformation
DE60215842D1 (de) Halter für simulierten rauchartikel
DE602004015886D1 (de) Vorrichtung zur Vorhersage von Kollisionen
NO20054078D0 (no) Humane antistoffer spesifikke for Interleukin 15 (IL15).
BRPI0418286A (pt) proteìnas de fusão de il-7
DE60231665D1 (de) Agarwood aus kulturmässigem Anbau
DE602004009744D1 (de) Reagenzbehälter
ATE424724T1 (de) Verwendung von n-arylhydrazinderivaten für die bekämpfung von schädlingen in und an tieren
DE60302814D1 (de) Vorrichtung für eine tierbezogene Handlung
DE60307249D1 (de) Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel
CY1110138T1 (el) Προσδιορισμος υψηλης διεκπεραιωτικοτητας της δραστικοτητας lp-pla2
DE60126479D1 (de) Vorrichtung zur mehrwertigen Modulation
WO2006039678A3 (en) Establishment of highly metastatic cell lines using nog mice
SE0300002L (sv) Ny produkt
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
EP1922620A4 (de) Erschaffung, entwurf, verwaltung, koordinierung, entwicklung und herstellung von produkten
DE60120425D1 (de) Verfahren zur herstellung von klonierten vögeln
ATE425962T1 (de) Peptid-deformylase-hemmer
DE602004017678D1 (de) Vorrichtung zur Verwaltung von Ressourcen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties